Insulin Ameliorates Neurodegeneration in an Experimental Animal Model of Brain Aging by a Decrease of GFAP Expression and Apoptosis Inhibition
Journal of Cellular and Molecular Anesthesia · 2024
DOI: 10.5812/jcma-145360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Anesthesia, 2024. Verfasst von Parnian Eslahi und 13 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Aging is one of the factors that will cause gradual changes in brain tissue and its destruction. One of the protective factors against aging is insulin.
Objectives
Our study investigated insulin's neuroprotective effect by preventing oxidative stress-mediated neuronal damage.
Methods
A total of 48 adult male NMRI (the Naval Medical Research Institute) mice were divided into 2 groups: Control and insulin. Insulin was administered intraperitoneally (IP) for 8 weeks to the control group and for 12 weeks to the insulin group. In this study, animals were treated with insulin, and insulin's role in the aging process was evaluated. Then, brain tissue was extracted for evaluation of oxidative stress by assessment of glutathione disulfide (GSH) and reactive oxygen species (ROS) levels, the expression of the glial fibrillary acidic protein (GFAP) as a biomarker for astrogliosis, stereological study, and the real-time polymerase chain reaction (PCR) technique evaluated the level of apoptosis biomarker.
Results
The results of stereological parameters show that the volumes of the brain cortex and the number of neurons improved in the insulin group by aging as compared to the control group. The results of real-time PCR showed that the expression level of apoptotic markers decreased in the insulin group compared to the control group. In the insulin group, GSH levels were higher than in the control group, and the control group produced more ROS than the insulin group. As compared with insulin, the control group expressed more GFAP protein and increased the number of glial cells by aging.
Conclusions
The results showed that insulin could have neuroprotective effects against aging changes and reduce apoptosis and cell death.
Zitieren
APA
Eslahi, P., Zavareh, M. A. T., Godaneh, M. K., Aliaghaei, A., Asghari, M. A., Payvandi, A. A., Younesi, A., Gheibi, M. M., Alvani, M. S., Fatabadi, F. F., Mohammadhosein, A., Omidvari, S., Abdollahifar, M., & Abbaszadeh, H. A. (2024). Insulin Ameliorates Neurodegeneration in an Experimental Animal Model of Brain Aging by a Decrease of GFAP Expression and Apoptosis Inhibition. Journal of Cellular and Molecular Anesthesia. https://doi.org/10.5812/jcma-145360
Vancouver
Eslahi P, Zavareh MAT, Godaneh MK, Aliaghaei A, Asghari MA, Payvandi AA, et al. Insulin Ameliorates Neurodegeneration in an Experimental Animal Model of Brain Aging by a Decrease of GFAP Expression and Apoptosis Inhibition. Journal of Cellular and Molecular Anesthesia. 2024. doi:10.5812/jcma-145360
BibTeX
@article{Eslahi2024,
author = {Eslahi, Parnian and Zavareh, Mohammad Amin Tofighi and Godaneh, Mohammadhosssein Kargar and Aliaghaei, Abbas and Asghari, Mohammad Ali and Payvandi, Ali Asghar and Younesi, Ali and Gheibi, Mohammad Mahdi and Alvani, Mohammadamin Sabbagh and Fatabadi, Fatemeh Fadaei and Mohammadhosein, Ali and Omidvari, Samareh and Abdollahifar, Mohammad-Amin and Abbaszadeh, Hojjat Allah},
title = {Insulin Ameliorates Neurodegeneration in an Experimental Animal Model of Brain Aging by a Decrease of GFAP Expression and Apoptosis Inhibition},
journal = {Journal of Cellular and Molecular Anesthesia},
year = {2024},
doi = {10.5812/jcma-145360}
}
EUVIMED